dc.creatorCiapponi, Agustín
dc.creatorTapia López, Elena
dc.creatorVirgilio, Sacha
dc.creatorBardach, Ariel Esteban
dc.date.accessioned2021-10-01T12:01:38Z
dc.date.accessioned2022-10-15T08:39:50Z
dc.date.available2021-10-01T12:01:38Z
dc.date.available2022-10-15T08:39:50Z
dc.date.created2021-10-01T12:01:38Z
dc.date.issued2020-07
dc.identifierCiapponi, Agustín; Tapia López, Elena; Virgilio, Sacha; Bardach, Ariel Esteban; The quality of clinical practice guidelines for preoperative care using the AGREE II instrument: A systematic review; BioMed Central; Systematic Reviews; 9; 1; 7-2020; 1-16
dc.identifier2046-4053
dc.identifierhttp://hdl.handle.net/11336/142205
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4366068
dc.description.abstractBackground: Our aim was to summarize and compare relevant recommendations from evidence-based CPGs (EB-CPGs). Methods: Systematic review of clinical practice guidelines. Data sources: PubMed, EMBase, Cochrane Library, LILACS, Tripdatabase, and additional sources. In July 2017, we searched CPGs that were published in the last 10 years, without language restrictions, in electronic databases, and also searched specific CPG sources, reference lists, and consulted experts. Pairs of independent reviewers selected EB-CPGs and rated their methodological quality using the AGREE-II instrument. We summarized recommendations, its supporting evidence, and strength of recommendations according to the GRADE methodology. Results: We included 16 EB-CPGs out of 2262 references identified. Only nine of them had searches within the last 5 years and seven used GRADE. The median (percentile 25-75) AGREE-II scores for rigor of development was 49% (35-76%) and the domain "applicability"obtained the worst score 16% (9-31%). We summarized 31 risk stratification recommendations, 21.6% of which were supported by high/moderate quality of evidence (41% of them were strong recommendations), and 16 therapeutic/preventive recommendations, 59% of which were supported by high/moderate quality of evidence (75.7% strong). We found inconsistency in ratings of evidence level. "Guidelines' applicability"and "monitoring"were the most deficient domains. Only half of the EB-CPGs were updated in the past 5 years. Conclusions: We present many strong recommendations that are ready to be considered for implementation as well as others to be interrupted, and we reveal opportunities to improve guidelines' quality.
dc.languageeng
dc.publisherBioMed Central
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1186/s13643-020-01404-8
dc.rightshttps://creativecommons.org/licenses/by/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAGREE-II
dc.subjectCLINICAL PRACTICE GUIDELINES
dc.subjectGRADE
dc.subjectPERIOPERATIVE CARE
dc.subjectSYSTEMATIC REVIEW
dc.titleThe quality of clinical practice guidelines for preoperative care using the AGREE II instrument: A systematic review
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución